Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1781880

Nan Fung Trinity (HK) Ltd

Investment managerFiled 2026-07-24 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$1.0B
Reported positions
55
Top holdings a year, 3 yrs
+19.6%
Average holding period
1.0 yrs

Nan Fung Trinity (HK) Ltd is an investment manager that reported 55 positions worth $1.0B in its Q2 2026 13F, filed 2026-07-24. Its largest holdings were Advanced Micro Devices Inc (AMD, 6.7%), Amcor PLC (AMCR, 5.1%), Ppg Inds Inc (PPG, 4.8%). A portfolio copying its top holdings returned 19.6% a year over the last 3 years, against 20.4% for the S&P 500.

Nan Fung Trinity (HK) Ltd holdings largest 50 of 55 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Nan Fung Trinity (HK) Ltd 13F holdings
Stock% of 13F valueShare changeReported value
AMDAdvanced Micro Devices Inc6.7%-27.8%$67.8M
AMCRAmcor PLC5.1%+7.5%$52.0M
PPGPpg Inds Inc4.8%+0.0%$48.2M
GEHCGe Healthcare Technologies I4.0%+202.7%$40.9M
NVDANvidia Corporation3.6%-21.7%$36.1M
HDHome Depot Inc3.5%+37.4%$35.2M
KTKt Corp3.3%+0.3%$33.8M
EIDOIshares Tr3.3%+33.3%$33.7M
MBBIshares Tr3.3%+0.0%$33.0M
OCOwens Corning New2.9%+37.0%$29.6M
UNHUnitedhealth Group Inc2.8%-34.4%$28.4M
APDAir Products and Chemicals I2.8%+0.0%$28.3M
IJHIshares Tr2.7%+0.0%$27.7M
AMXAmerica Movil Sab de Cv2.7%-20.2%$27.4M
MIRMMirum Pharmaceuticals Inc2.7%+0.0%$27.2M
DHRDanaher Corp Del2.4%+28.3%$24.1M
TRVITrevi Therapeutics Inc2.2%+6.2%$22.6M
METAMeta Platforms Inc2.1%+145.8%$21.0M
PTGXProtagonist Therapeutics Inc1.9%+0.0%$19.7M
ABVXAbivax SA1.9%+10.2%$18.9M
XHBSpdr Series Trust1.8%+0.0%$17.9M
JDJd.com Inc1.6%+0.0%$16.6M
BBIOBridgebio Pharma Inc1.6%+0.0%$16.3M
MPMp Materials Corp1.6%+0.0%$15.9M
PDDPdd Holdings Inc1.6%+35.8%$15.8M
SRRKScholar Rock Hldg Corp1.6%+0.0%$15.7M
WBDWarner Bros Discovery Inc1.5%+0.0%$15.3M
IMNMImmunome Inc1.5%+0.0%$15.1M
XENEXenon Pharmaceuticals Inc1.5%+0.0%$15.0M
IRENIren Limited1.3%—$13.5M
KURAKura Oncology Inc1.3%+10.3%$12.9M
BCAXBicara Therapeutics Inc1.3%+0.0%$12.7M
AREAlexandria Real Estate Eq in1.2%+0.0%$12.6M
HONHoneywell Intl Inc1.2%—$12.3M
HONAHoneywell Aerospace Inc1.2%—$12.2M
VORVor Biopharma Inc1.2%—$11.9M
FLEXFlex Ltd Ord1.2%—$11.7M
CRHCrh PLC1.1%—$11.4M
SVRASavara Inc1.1%+0.0%$11.3M
CELCCelcuity Inc1.1%+0.0%$10.9M
BXPBxp Inc0.8%+0.0%$8.1M
KRCKilroy Realty Corp0.8%+0.0%$7.9M
PCVXVaxcyte Inc0.7%+0.0%$7.1M
SLGSl Green Rlty Corp0.7%-2.4%$6.9M
ZLABZai Lab Ltd0.7%+0.0%$6.6M
ABEOAbeona Therapeutics0.6%+0.0%$5.9M
VNOVornado Rlty Tr0.6%—$5.7M
QUREUniqure NV0.5%—$5.3M
CLYMClimb Bio Inc0.5%—$4.7M
BCRXBiocryst Pharmaceuticals Inc0.4%—$4.5M

What Nan Fung Trinity (HK) Ltd bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Added to

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+34.2% /yr
S&P 500 +20.1%
3 years
+19.6% /yr
S&P 500 +20.4%
5 years
+10.1% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$1.0B55
Q1 2026$910.6M62
Q4 2025$1.3B78
Q3 2025$1.0B71
Q2 2025$835.8M59
Q1 2025$630.5M39
Q4 2024$489.7M30
Q3 2024$498.4M24
Q2 2024$437.9M22
Q1 2024$432.4M26
Q4 2023$482.5M24
Q3 2023$555.0M30

Questions about Nan Fung Trinity (HK) Ltd's portfolio

What stocks does Nan Fung Trinity (HK) Ltd own?

Nan Fung Trinity (HK) Ltd's latest 13F, for Q2 2026 and filed Jul 24, 2026, lists 55 positions worth $1.0B. The largest are Advanced Micro Devices Inc (AMD) at 6.7%, Amcor PLC (AMCR) at 5.1%, Ppg Inds Inc (PPG) at 4.8%, Ge Healthcare Technologies I (GEHC) at 4.0% and Nvidia Corporation (NVDA) at 3.6%.

What did Nan Fung Trinity (HK) Ltd buy last quarter?

In Q2 2026, Nan Fung Trinity (HK) Ltd added Ge Healthcare Technologies I (GEHC) (+202.7% shares), Meta Platforms Inc (META) (+145.8% shares) and Home Depot Inc (HD) (+37.4% shares), compared with its Q1 2026 filing.

What did Nan Fung Trinity (HK) Ltd sell last quarter?

In Q2 2026, Nan Fung Trinity (HK) Ltd cut from its top 50 Ishares Inc (THD), cut from its top 50 Honeywell Intl. Inc (HON), cut from its top 50 Pinterest Inc (PINS), cut from its top 50 Target Corp (TGT), cut from its top 50 Microchip Technology Inc. (MCHP), Unitedhealth Group Inc (UNH) (-34.4% shares), Advanced Micro Devices Inc (AMD) (-27.8% shares) and Nvidia Corporation (NVDA) (-21.7% shares), compared with its Q1 2026 filing.

How has Nan Fung Trinity (HK) Ltd's portfolio performed?

A portfolio copying Nan Fung Trinity (HK) Ltd's 20 largest 13F holdings each quarter, from the day each filing was public, returned +19.6% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +34.2% against +20.1%. Over 5 years: +10.1% a year against +11.6%.

When is Nan Fung Trinity (HK) Ltd's next 13F filing due?

13F filings are due 45 days after each quarter ends. Nan Fung Trinity (HK) Ltd's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.